News

News

 

Find Sector or Specific Portfolio
Company News

 

Or

 
 

Aperio Contributes to DICOM Pathology Standard to Improve Patient Care

 

Aperio Technologies, Inc.
Medical Devices & Technology
 
Update: Friday, 10 December 2010

Aperio, the global leader in providing digital pathology solutions to improve patient care, contributed to the expansion of the Digital Imaging and Communication in Medicine´s (DICOM) medical image exchange standard Supplement 145, Whole-Slide Microscopic Images, the first for pathology.

 

Supplement 145 creates a single standard for the electronic display, sharing, storage and management of digital slides for pathology, helping pathologists to validate the quality of these slides and ultimately enhance patient care. The Supplement also facilitates inter-operability between systems managing medical images, such as pathology, radiology and other medical imaging systems.

 

"Supplement 145 was a multi-vendor effort, which resulted in a solid enhancement to the DICOM standard to include digital pathology among the supported medical modalities," commented Ole Eichhorn, chief technology officer of Aperio. "This type of standards effort will foster adoption of digital pathology by assuring hospitals and labs of inter-operability between systems."

 

Aperio has consistently supported efforts to create standards for digital pathology, and was a founding member of DICOM Working Group 26, which created Supplement 145. Aperio will support the new standard and continue to work with other medical imaging vendors to foster compatibility between systems.

 

"As a key member of DICOM Working Group 26, Aperio contributed significantly to the creation of Supplement 145", said Bruce A. Beckwith, MD, FCAP, chair, Department of Pathology, North Shore Medical Center, Salem, Mass. and co-chairman of DICOM Working Group 26. "The College of American Pathologists was pleased to facilitate the formation of this multi-vendor standard."

 

The addition of Supplement 145 to the DICOM standard complements a previous effort by Working Group 26 which resulted in Supplement 122, a specimen model for Pathology.

 

About Aperio

Aperio is the leading provider of digital pathology solutions in hospitals, reference labs, and pharmaceutical and research institutions across the world. Today, our affordable and complete product portfolio improves patient care by enhancing quality assurance, delivering more efficient workflows, facilitating access to new and more targeted therapies, and improving pathologists´ skills via lifelong education.

 

Our comprehensive product line features our ScanScope® scanners, SpectrumTM image management (PACS) software, SecondSlide® slide sharing service for pathology, and image analysis tools and services. Aperio´s products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For clearance updates and more information please visit www.aperio.com :  .

 

Aperio, Jessica Witkowski, 760-539-1162, Director, Marketing
Communications jessica@aperio.com : mailto:jessica@aperio.com

or

Myla Wagner Public Relations, Myla Wagner, 925-736-7515 myla@mylawagnerpr.com : mailto:myla@mylawagnerpr.com